Duobrii Lotion
Product Images NDC 0187-0653

4 FDA label images from Bausch Health Us, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Duobrii (NDC 0187-0653). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bausch Health Us, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton

Carton
Duobrii lotion 0.01% / 0.045% (halobetasol propionate and tazarotene) topical lotion label for a 100 g package. The label includes usage instructions indicating it is for topical use only and not for eye use. It is distributed by Bausch Health US, LLC and manufactured by Bausch Health Companies Inc., Canada. The design features geometric color gradients and the Ortho Dermatologics logo.*
FDA Label Image

Chem1.jpg (Chem1)

Chem1.jpg (Chem1)
Chemical structure diagram showing the molecular formula of halobetasol propionate, an active ingredient in Duobrii lotion for topical use.*
FDA Label Image

Chem2.jpg (Chem2)

Chem2.jpg (Chem2)
Chemical structure of tazarotene, one of the active ingredients in Duobrii (halobetasol propionate and tazarotene) topical lotion.*
FDA Label Image

Figure1 (Image 01)

Figure1 (Image 01)
A two-panel line graph showing treatment success rates over 12 weeks comparing Duobrii lotion versus vehicle. Both trials display the percentage of subjects with treatment success on the y-axis and weeks on the x-axis. Duobrii shows increasing success up to week 8, then a slight decrease during a 4-week no treatment follow-up. Vehicle success rates remain low and stable throughout.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.